~ Comprehensive Rare Cancers Program offers clinical expertise for accurate diagnosis so
treatment is initiated faster leading to better patient outcomes
29th August, 2024 (Odisha Tazanews) Mumbai MMR :-> For patients grappling with the uncertainty and fear that come with rare cancers, finding the right diagnosis and care can feel like an overwhelming challenge. At Apollo Hospitals’ RareCare Clinic, hope is now within reach. The specialized clinic, located at the Apollo Hospitals in Navi Mumbai, is dedicated to providing comprehensive, compassionate care to those facing the unique struggles of rare and challenging cancers which are often wrongly diagnosed treated leading to poor outcomes for the patient. Rare cancers, though individually uncommon with an incidence of 6 in 100,000, collectively represent a significant 20% of all cancer cases. With over 200 identified types, these cancers often leave patients feeling isolated and uncertain due to the lack of available data on diagnostic processes and treatment protocols. Rare cancers include Bone and soft tissue sarcomas (Desmoid tumors), Skin cancer,
Pregnancy associated cancers, Cancers in sexual minority populations (LGBTQ+ cancers), Neuroendocrine tumors (NETs), Hereditary familial cancers, and Adolescent or young adult cancers. Challenging situations in Oncology includes Geriatric cancer with comorbidities, Immuno compromised situations, Patients with comorbities and poly pill therapies, Uncommon presentations or rare histologies of common cancers, such as breast, gynaecological, lung, gastrointestinal, and head and neck cancers. Dr. Jyoti Bajpai, Lead – Medical Precision Oncology, Apollo Hospitals Navi Mumbai said, & Early diagnosis is crucial with rare cancers, as they often present with symptoms that can be easily mistaken for other conditions. Having been an active member of global cancer associations like Society of Immunotherapy in Cancers (SITC), Faculty for Immuno-Oncology at European Society of Medical Oncology (ESMO) and immediate past faculty for Sarcomas as well as core committee member for
